Global Bioinformatics Market Projected to Reach USD 9.1 Billion in 2018
|
By LabMedica International staff writers Posted on 10 Dec 2012 |
|
Projected to record double-digit growth, the global informatics market will have the highest revenue contribution from the platforms segment.
The global bioinformatics market, estimated at USD 2.3 billion in 2012, is forecasted to reach a market size of USD 9.1 billion in 2018, at a compounded annual growth rate (CAGR) of 25.4% from 2012-2018, according to Transparency Market Research (Albany, NY, USA; www.transparencymarketresearch.com). The market growth is motivated by a rise in applications across a range of industries. The major contribution to the market demand is from fields such as pharmaceutical research and development, agriculture biotechnology, medical and clinical diagnostics, and other life-sciences related industries.
The services market currently holds a comparatively smaller market share; however, it is expected to increase considerably over the forecast period. The bioinformatics platform segment is the fastest growing market and is expected to contribute 54% of the total market growth during the same period.
Research outsourcing by pharmaceutical giants in the fields comprising bioinformatics content is a significant driver of the global bioinformatics market. These companies, in efforts to decrease time and costs on R&D activities involved in the development of new medicines and new applications for existing drugs, are looking for outsourcing services for bioinformatics knowledge and management tools, platforms, and services.
North America holds the largest share among the regional markets; it, however, is forecasted to be superseded by Europe as the leading market shareholder in 2018, because of rapid growth seen by major European markets such as the United Kingdom and Germany. Europe is predicted to be the fastest growing region, with growth chiefly driven by mounting government support for R&D activities in the region. The bioinformatics services market in Europe and North America is well established and organized, while it is still in an early growth phase in emerging markets of Asia Pacific region.
Related Links:
Transparency Market Research
The global bioinformatics market, estimated at USD 2.3 billion in 2012, is forecasted to reach a market size of USD 9.1 billion in 2018, at a compounded annual growth rate (CAGR) of 25.4% from 2012-2018, according to Transparency Market Research (Albany, NY, USA; www.transparencymarketresearch.com). The market growth is motivated by a rise in applications across a range of industries. The major contribution to the market demand is from fields such as pharmaceutical research and development, agriculture biotechnology, medical and clinical diagnostics, and other life-sciences related industries.
The services market currently holds a comparatively smaller market share; however, it is expected to increase considerably over the forecast period. The bioinformatics platform segment is the fastest growing market and is expected to contribute 54% of the total market growth during the same period.
Research outsourcing by pharmaceutical giants in the fields comprising bioinformatics content is a significant driver of the global bioinformatics market. These companies, in efforts to decrease time and costs on R&D activities involved in the development of new medicines and new applications for existing drugs, are looking for outsourcing services for bioinformatics knowledge and management tools, platforms, and services.
North America holds the largest share among the regional markets; it, however, is forecasted to be superseded by Europe as the leading market shareholder in 2018, because of rapid growth seen by major European markets such as the United Kingdom and Germany. Europe is predicted to be the fastest growing region, with growth chiefly driven by mounting government support for R&D activities in the region. The bioinformatics services market in Europe and North America is well established and organized, while it is still in an early growth phase in emerging markets of Asia Pacific region.
Related Links:
Transparency Market Research
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Pipette Calibration System
Artel PCS®
New
Total Laboratory Automation Solution
SATLARS Mini T8
Latest BioResearch News
- Study Links Midlife Vitamin D to Lower Tau in Alzheimer's
- International Consensus Standardizes Tumor Microbiota Detection and Reporting
- Common Metablolic Enzyme Could Predict Response to Cancer Immunotherapy
- Newly Identfied Genetic Variants in MND Support Prognosis and Family Testing
- Innate Immunity Variants Associated With Earlier Breast Cancer in BRCA1 Carriers
- Genetic Cause Identified for Severe Infant Epilepsy
- Study Reveals Diagnostic and Therapeutic Target in Rare Pancreatic Tumors
- Researchers Identify Survival Pathway Undermining Targeted Cancer Drugs
- Large-Scale Study Maps DNA Damage Signatures Across Multiple Cancers
- Study Identifies Distinct Immune Signatures to Early Depression and Psychosis
- Genetic Mutation Behind Aggressive Adult Leukemia Offers Treatment Clues
- Disease Gene Discovery Advances Diagnosis of Rare Movement Disorders
- Genetic Discovery Could Improve Diagnosis of Drug-Resistant Epilepsy
- Genetic Discovery May Improve Diagnosis of Rare Dementia Subtype
- Mass Spectrometry Technique Detects Protein and Sugar Changes in Neurodegeneration
- Barcoded DNA Sheds Light on Hidden Complexities in Breast Cancer Detection
Channels
Clinical Chemistry
view channel
Blood Metabolite Test Detects Early Cognitive Decline
Timely identification of individuals at risk of dementia remains difficult because symptoms commonly appear only after significant neurodegeneration. Accessible screening tools that flag subtle cognitive... Read more
AI-Based Blood Test Diagnose Multiple Brain Disorders from Blood Sample
Diagnosing the cause of age-related cognitive symptoms remains challenging because clinical presentations of neurodegenerative diseases often overlap, and multiple pathologies can co-occur... Read more
Molecular Diagnostics
view channel
cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample
Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read more
Rapid Point-of-Care RT-PCR Test Differentiates Influenza A/B and SARS-CoV-2 in Minutes
Respiratory viruses such as influenza A/B and SARS‑CoV‑2 continue to burden urgent care and emergency settings, where rapid, reliable differentiation guides therapy and infection control.... Read more
Hematology
view channel
AI-Powered Digital Workflow Standardizes Bone Marrow Aspirate Morphology
Bone marrow aspirate examination is central to diagnosing and monitoring blood cancers and other serious hematologic diseases, yet the process in many laboratories remains manual and highly dependent on... Read more
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
Immunology
view channel
Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read more
Microbiology
view channel
New Bacterial Target Identified for Early Detection of Noma
Noma is a rapidly progressing orofacial infection that begins as gingivitis and can destroy oral and facial tissues, primarily affecting young children living in extreme poverty. Without treatment, it... Read more
Genomic Analysis Links Emerging Streptococcal Strains to Specific Infections
Streptococcus dysgalactiae subspecies equisimilis (SDSE) infections are increasing worldwide and include variants that may lead to severe disease. Researchers now report that whole-genome sequencing of... Read more
Pathology
view channel_image.png "Image: Through neoadjuvant therapy combining chemotherapy with immune checkpoint inhibitors (ICI) for 46 LAGC patients and single-cell transcriptome sequencing, researchers found that tumor cells in the treatment-sensitive group specifically upregulated MHC-II (tumor-specific major histocompatibility complex class II, tsMHC-II) molecules (photo courtesy of Science China Press)")
Tumor-Specific Biomarker Predicts Neoadjuvant Immunotherapy Response in Gastric Cancer
Gastric cancer is the fifth most common malignancy and the fourth leading cause of cancer mortality worldwide, with China bearing nearly half of the global burden. Only a subset of patients benefit from... Read more
AI Tool Predicts Patient-Specific Chemotherapy Benefit in Breast Cancer
Selecting adjuvant chemotherapy for early-stage breast cancer is typically guided by recurrence risk and population-level averages rather than patient-specific benefit. However, existing clinicopathologic... Read more
Technology
view channel
New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
Children with T-cell acute lymphoblastic leukemia face an aggressive disease that remains difficult to treat. Although remission rates have improved, many survivors experience long-term effects from intensive... Read more
Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
Mass spectrometry is central to identifying and quantifying molecules in complex biological samples, but conventional instruments typically analyze ions sequentially, which can limit detection of rare species.... Read more
Industry
view channel
Global Partnership Aims to Streamline NGS Tumor Profiling in Oncology Trials
CellCarta and Pillar Biosciences announced a global, multi-year strategic partnership on April 2, 2026 to broaden access to operationally streamlined next-generation sequencing (NGS) tumor profiling for... Read more
